Investors following Inspire Medical Systems, Inc. (NYSE:INSP) should note that Director Jerry C. Griffin has recently engaged in significant trading activity. According to the latest SEC filings, Griffin sold a total of 554 shares of common stock at a price of $197.81 each, amounting to over $108,000.
This sale took place on March 25, under a pre-arranged Rule 10b5-1 trading plan, which allows company insiders to sell shares at predetermined times to avoid accusations of insider trading. The filings also show that Griffin acquired 1,000 shares of Inspire Medical Systems through the exercise of stock options, with a strike price of $16.00 per share, totaling $16,000.
The transactions have adjusted Griffin's holdings in the company, but he still maintains a significant investment in Inspire Medical Systems. After the reported transactions, Griffin's direct ownership in the company stands at 10,636 shares of common stock.
For investors, insider transactions can serve as a valuable signal, providing insights into how company executives view the stock's value and prospects. Griffin's recent sale and option exercise are part of the normal course of stock ownership for corporate insiders but are notable for their size and timing.
Inspire Medical Systems, Inc., headquartered in Golden Valley, Minnesota, specializes in surgical and medical instruments and apparatus. The company's activities and financial developments are closely watched by investors interested in the medical technology sector.
InvestingPro Insights
In light of the recent insider trading activity at Inspire Medical Systems, Inc. (NYSE:INSP), investors may be seeking additional context to assess the company's financial health and market position. According to InvestingPro data, Inspire Medical Systems has a market capitalization of $6.46 billion and has experienced a significant revenue growth of 53.19% in the last twelve months as of Q4 2023. Despite this growth, the company's high Price / Book multiple of 11.3 suggests that the stock is trading at a premium compared to the book value of its assets.
InvestingPro Tips indicate that analysts do not expect the company to be profitable this year, which is reflected in the negative P/E ratios for the last twelve months (-305.89). Nevertheless, Inspire Medical Systems operates with a moderate level of debt and has liquid assets that exceed its short-term obligations, providing some financial stability for the company. Additionally, the company has seen a strong return over the last month, with a 12.61% price total return, which might capture the interest of investors looking for recent positive performance.
For those considering an investment in Inspire Medical Systems, or for current shareholders seeking to deepen their analysis, InvestingPro offers additional insights. There are numerous other InvestingPro Tips available, which could further inform investment decisions. As a special offer, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.